News

News // Emery Pharma Sponsors PDA Event on Artificial Intelligence in Biopharmaceutical Development and Manufacturing

Emery Pharma Sponsors PDA Event on Artificial Intelligence in Biopharmaceutical Development and Manufacturing

Alameda, CA  – Emery Pharma, a leader in analytical testing and research services, is proud to announce its sponsorship of the upcoming Parenteral Drug Association (PDA) event, Artificial Intelligence in Biopharmaceutical Development and Manufacturing. This prestigious conference, scheduled for March 20-21, 2025 in Las Vegas, Nevada, will bring together industry experts, researchers, and regulators to explore the transformative role of artificial intelligence (AI) in drug development and manufacturing.

AI is rapidly reshaping the pharmaceutical industry, optimizing processes, enhancing drug discovery, and improving manufacturing efficiencies. As a company committed to innovation, Emery Pharma recognizes the critical role AI plays in driving advancements in biopharmaceuticals. By sponsoring this event, Emery Pharma aims to support knowledge-sharing and collaboration among industry leaders striving for safer, more effective therapies.

“We are excited to be part of this forward-thinking discussion on AI’s integration into biopharmaceutical development,” said Dr. Ron Najafi, Founder and CEO at Emery Pharma. “Our mission is to leverage cutting-edge analytical techniques and regulatory expertise to ensure the highest standards of drug safety and efficacy. AI presents a remarkable opportunity to advance these goals.”

The PDA event will feature keynotes from leading scientists and industry professionals, panel discussions, and case studies showcasing real-world applications of AI in areas such as quality control, process automation, and predictive analytics.

Emery Pharma invites attendees to visit our representatives at the event to learn more about our analytical solutions and how we are integrating AI-driven approaches into our research and development efforts.

About Emery Pharma:
Emery Pharma is a full-service contract research laboratory specializing in analytical testing, microbiology, and mass spectrometry. Our team of experts provides comprehensive solutions to support drug development, regulatory compliance, and quality assurance for the pharmaceutical and biotechnology industries.

Media Contact at Emery Pharma:
Chris Purcell
Business Development Manager
cpurcell@emerypharma.com
emerypharma.com